|
GB1555654A
(en)
*
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
US4065562A
(en)
*
|
1975-12-29 |
1977-12-27 |
Nippon Shinyaku Co., Ltd. |
Method and composition for reducing blood glucose levels
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
GB2020278B
(en)
*
|
1978-05-03 |
1983-02-23 |
Nippon Shinyaku Co Ltd |
Moranoline dervitives
|
|
JPS568318A
(en)
|
1979-06-28 |
1981-01-28 |
Janssen Pharmaceutica Nv |
Non oral long acting composition of haloperidol and bromperidol derivative
|
|
GB8311286D0
(en)
|
1983-04-26 |
1983-06-02 |
Searle & Co |
Carboxyalkyl peptide derivatives
|
|
EP0144290A3
(de)
|
1983-12-01 |
1987-05-27 |
Ciba-Geigy Ag |
Substituierte Aethylendiaminderivate
|
|
US5041441A
(en)
|
1988-04-04 |
1991-08-20 |
The Regents Of The University Of Michigan |
Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
|
|
US5302609A
(en)
*
|
1992-12-16 |
1994-04-12 |
The Regents Of The University Of Michigan |
Treatment of diabetic nephropathy
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
US5707649A
(en)
|
1993-08-13 |
1998-01-13 |
Seikagaku Corporation |
Agent for treating neuronal diseases
|
|
ATE195944T1
(de)
|
1994-02-02 |
2000-09-15 |
Liposome Co Inc |
Pharmazeutisch wirksame verbindungen und liposome und verfahren zu deren herstellung
|
|
WO1995034530A1
(en)
|
1994-06-10 |
1995-12-21 |
Seikagaku Corporation |
2-acylaminopropanol compound and medicinal composition
|
|
WO2001004108A1
(en)
|
1999-07-09 |
2001-01-18 |
Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20030073680A1
(en)
|
1995-09-20 |
2003-04-17 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6255336B1
(en)
*
|
1995-09-20 |
2001-07-03 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US5916911A
(en)
|
1995-09-20 |
1999-06-29 |
The Regents Of The University Of Michigan |
Amino ceramide--like compounds and therapeutic methods of use
|
|
NO965193L
(no)
|
1995-12-08 |
1997-06-09 |
Seikagaku Kogyo Kk Seikagaku C |
Aminalkoholderivat og fremgangsmåte for fremstilling derav
|
|
JP3993908B2
(ja)
|
1995-12-08 |
2007-10-17 |
生化学工業株式会社 |
アミノアルコール誘導体及び該誘導体の製造方法
|
|
JP4140984B2
(ja)
|
1995-12-20 |
2008-08-27 |
生化学工業株式会社 |
分化誘導作用を有する薬剤
|
|
JP2871565B2
(ja)
|
1995-12-26 |
1999-03-17 |
株式会社神戸製鋼所 |
ローラヘッド押出機とその制御方法
|
|
US5972928A
(en)
*
|
1997-05-21 |
1999-10-26 |
Johns Hopkins University |
Methods for treatment of conditions associated with lactosylceramide
|
|
JP4036500B2
(ja)
|
1997-05-23 |
2008-01-23 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
JP4176170B2
(ja)
|
1997-06-06 |
2008-11-05 |
生化学工業株式会社 |
アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬
|
|
US6465488B1
(en)
*
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
|
ES2285852T3
(es)
|
1998-07-27 |
2007-11-16 |
Johns Hopkins University |
Compuestos de diamino-propanol para el tratamiento de la isquemia.
|
|
US6610703B1
(en)
*
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB0100889D0
(en)
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
EP1384719A1
(en)
|
1999-07-09 |
2004-01-28 |
The Regents of The University of Michigan |
Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections
|
|
EP1196406A1
(en)
*
|
1999-07-09 |
2002-04-17 |
The Regents of the University of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP5009459B2
(ja)
|
1999-12-06 |
2012-08-22 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
US6407064B2
(en)
*
|
1999-12-06 |
2002-06-18 |
Seikagaku Corporation |
Aminoalcohol derivative and medicament comprising the same
|
|
US6235737B1
(en)
|
2000-01-25 |
2001-05-22 |
Peter Styczynski |
Reduction of hair growth
|
|
WO2001080852A1
(en)
|
2000-04-19 |
2001-11-01 |
Borody Thomas J |
Compositions and therapies for hyperlipidaemia-associated disorders
|
|
JP2005506949A
(ja)
|
2000-12-20 |
2005-03-10 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
ケモカイン受容体の調節剤としてのジアミン
|
|
JP2004523509A
(ja)
|
2000-12-29 |
2004-08-05 |
ワイス |
ベンゾ〔ｇ〕キノリン−３−カルボニトリルの置換体およびベンゾ〔ｇ〕キナゾリンの置換体の位置選択的調製方法
|
|
US7148251B2
(en)
|
2001-01-10 |
2006-12-12 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
CA2434028C
(en)
|
2001-01-10 |
2010-11-09 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20020198240A1
(en)
|
2001-01-10 |
2002-12-26 |
Shayman James A. |
Amino ceramide - like compounds and therapeutic methods of use
|
|
US20040260099A1
(en)
|
2001-01-10 |
2004-12-23 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
EP2266968B1
(en)
*
|
2001-07-16 |
2013-01-09 |
Genzyme Corporation |
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
|
|
AU2002348261A1
(en)
|
2001-11-26 |
2003-06-10 |
Genzyme Corporation |
Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
|
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2003057874A1
(fr)
|
2001-12-28 |
2003-07-17 |
Sumitomo Pharmaceuticals Company, Limited |
Marqueurs de maladies pour maladies renales et leur utilisation
|
|
DE60303009T2
(de)
|
2002-01-22 |
2006-07-13 |
Warner-Lambert Co. Llc |
2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-one
|
|
EP1336411A1
(en)
|
2002-02-14 |
2003-08-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
|
|
JP2003238410A
(ja)
|
2002-02-21 |
2003-08-27 |
Seibutsu Yuki Kagaku Kenkyusho:Kk |
インスリン抵抗性解除剤
|
|
US6916802B2
(en)
|
2002-04-29 |
2005-07-12 |
Genzyme Corporation |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20060217560A1
(en)
|
2002-04-29 |
2006-09-28 |
Shayman James A |
Amino ceramide-like compounds and therapeutic methods of use
|
|
GEP20084499B
(en)
|
2002-07-17 |
2008-10-10 |
Biogen Idec Inc |
USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE
|
|
EP1534676B1
(en)
|
2002-07-17 |
2012-09-12 |
Actelion Pharmaceuticals Ltd. |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
AU2003225670A1
(en)
|
2003-02-28 |
2004-09-28 |
Intermune, Inc. |
Interferon drug therapy for the treatment of viral diseases and liver fibrosis
|
|
GB0313678D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
ATE491451T1
(de)
|
2003-10-29 |
2011-01-15 |
Genzyme Corp |
N-(5-adamantane-1-yl-methoxy- pentyl)desoxynojirimycin oder eines pharmazeutischen salzes davon zur verwendung bei der behandlung der insulinresistenz
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
AU2004308966A1
(en)
|
2003-12-23 |
2005-07-14 |
Musc Foundaton For Research Development |
Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JP5154218B2
(ja)
|
2004-03-16 |
2013-02-27 |
ネーデルランドセ オルガニサティエ フォール トエゲパスト−ナトールヴェテンシャッペリク オンデルゾエク ティエヌオー |
２型糖尿病、インスリン抵抗性及びメタボリック症候群の治療及び予防においてスフィンゴ脂質を使用する方法
|
|
EP1576894A1
(en)
|
2004-03-16 |
2005-09-21 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome
|
|
AU2005240714B2
(en)
|
2004-05-07 |
2011-07-07 |
Merck Patent Gmbh |
GM3 synthase as a therapeutic target in microvascular complications of diabetes
|
|
ZA200700024B
(en)
*
|
2004-05-26 |
2008-06-25 |
Fasgen Llc |
Novel compounds, pharmaceutical compositions containing same, and methods of use for same
|
|
US20090111812A1
(en)
|
2004-06-14 |
2009-04-30 |
Musc Foundation For Research Development |
Methods for treating inflammatory disorders
|
|
AU2005277186A1
(en)
|
2004-08-20 |
2006-03-02 |
The Johns Hopkins University |
Methods for treatment of angiogenesis
|
|
CA2586761A1
(en)
*
|
2004-11-10 |
2006-05-18 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
CN101151248B
(zh)
|
2005-01-26 |
2012-06-20 |
阿勒根公司 |
具有镇痛活性和/或免疫刺激物活性的3-芳基-3-羟基-2-氨基丙酸酰胺类、3-杂芳基-3-羟基-2-氨基丙酸酰胺类以及相关化合物
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
EP2032134B1
(en)
|
2006-05-09 |
2015-06-24 |
Genzyme Corporation |
Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
|
|
WO2008011478A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
WO2008011487A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
US20100239551A1
(en)
|
2007-02-09 |
2010-09-23 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
US8304447B2
(en)
*
|
2007-05-31 |
2012-11-06 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|
|
KR20160085917A
(ko)
|
2007-10-05 |
2016-07-18 |
젠자임 코포레이션 |
세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
|
|
WO2009117150A2
(en)
|
2008-03-20 |
2009-09-24 |
Genzyme Corporation |
Method of treating lupus with ceramide derivatives
|
|
WO2010014554A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
|
US8309593B2
(en)
*
|
2008-10-03 |
2012-11-13 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|